CoChat

Adjudication of serious heart failure in patients from PROactive

Open access
Rydén, Lars, Thráinsdóttir, Inga, Swedberg, Karl · 2007 · The Lancet

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)60106-8

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 6 references

Cited by

See all 41

Metadata

Authors
Rydén, L., Thráinsdóttir, I., & Swedberg, K.
Affiliations
Karolinska University Hospital (SE)
Corresponding author
Rydén, Lars
Venue
The Lancet
Publisher
Elsevier BV
Published
2007-01
Volume
369
Issue
9557
Pages
189-190
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2083719627
Cited by
41
References
6
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2018: 4 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2012: 1
FWCI
5.13
Type
journal article
Language
en
Open access
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
heart failure, pioglitazone, PROactive trial, adjudication, type 2 diabetes, adverse events, peripheral edema, weight gain, macrovascular complications, SGLT2 inhibitors
MeSH terms
Pioglitazone, Heart Failure, Hospitalization, Humans, Hypoglycemic Agents, Pneumonia, Hospital Mortality, Thiazolidinediones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjudication of serious heart failure in patients from PROactive. https://app.cochat.ai/papers/10.1016/s0140-6736(07)60106-8
The paper
Rydén, L., Thráinsdóttir, I., & Swedberg, K. (2007). Adjudication of serious heart failure in patients from PROactive. The Lancet. https://doi.org/10.1016/s0140-6736(07)60106-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.